ECE2017 Eposter Presentations: Thyroid Thyroid (non-cancer) (260 abstracts)
Iodine content of iodized salt in Spain
Vanessa Arosa 1 , Maider Sánchez Goitia 1 , Mercedes Espada 2, , Luis Irigoyen 1 , Gonzalo Maldonado 1 , Juan José Arrizabalaga 1, , Piedad Santiago 3, , María Orosia 4, , Edelmiro Menéndez 5, , Lluís Vila 6, , Silvia Wengrowicz 7, & Sergio Donnay 8,
1Endocrinology and Nutrition Department, Hospital Universitario Araba, Vitoria-Gasteiz, Spain; 2Unidad de Química Clínica, Laboratorio Normativo de Salud Pública, Departamento de Sanidad y Consumo del Gobierno Vasco, Derio, Spain; 3Endocrinology and Nutrition Department, Complejo Hospitalario de Jaén, Jaén, Spain; 4Endocrinology and Nutrition Department, Hospital Royo Villanova, Zaragoza, Spain; 5Endocrinology and Nutrition Department, Hospital Central de Asturias, Oviedo, Spain; 6Endocrinology and Nutrition Department, Hospital de Sant Joan Despí Moisès Broggi, Sant Joan Despí, Spain; 7Instituto Catalán de Endocrinología, Barcelona, Spain; 8Endocrinology and Nutrition Department, Fundación Hospital Alcorcón, Alcorcón, Spain; 9Área de Conocimiento del Tiroides de la Sociedad Española de Endocrinología y Nutrición, Madrid, Spain.
Introduction: Optimization of iodine intake aims to prevent the irreversible damage that iodine deficiency (ID) can cause in the central nervous system during its development, as well as thyroid disorders that can be induced by both ID and excessive micronutrient intake. The Spanish legal regulation stipulates that iodized salt (IS) must contain 60 mg of iodine per kg of salt (60 ppm), allowing a tolerance of ±15%. The aim of this study is to address the iodine content of different commercially available IS in Spain.
Methods: 162 different IS lots from 51 different product presentations were collected from Spanish food stores in Andalusia, Aragon, Asturias, Balearic Islands, Catalonia, Madrid and Basque Country between 2014 and 2016. Iodine concentration in these samples was assessed by HDL-chromatography (HPLC).
Results: The mean (S.D.) and median (P25–P75) iodine concentration for these 162 samples was 61.2 (19.7) and 59 (50–70) μg I/g salt, respectively. Iodine concentration dispersion was mainly attributable to iodide-fortified IS (n=67). The analysis of these fortified IS revealed that 67.2% of them had iodine levels out of the legal threshold (51–69 μg I/g salt), whereas only 43.2% of the iodate-fortified IS (n=95) were outside this limit (P<0.05).
Conclusions: IS, having an average 60 μg I/g salt, is an important alimentary source of iodine in Spain. The use of iodate instead of iodide for the fortification of the salt allows a greater proportion of IS with iodine concentration within the legal limits. Public Health and Consumer Affairs authorities should closely monitor IS production processes and eventually check IS sale points in order to homogenize the iodine content of commercially available IS packages and thereby optimize their intake by the population.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more